Cargando…
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data
Postmarketing surveillance is useful to collect safety data in real‐world clinical settings. In this study, we applied postmarketing real‐world data on a mechanistic model analysis for neutropenic profiles of eribulin in patients with recurrent or metastatic breast cancer. Demographic and safety dat...
Autores principales: | Kawamura, Takahisa, Kasai, Hidefumi, Fermanelli, Valentina, Takahashi, Toshiaki, Sakata, Yukinori, Matsuoka, Toshiyuki, Ishii, Mika, Tanigawara, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125471/ https://www.ncbi.nlm.nih.gov/pubmed/29933506 http://dx.doi.org/10.1111/cas.13708 |
Ejemplares similares
-
Pharmacodynamic analysis of hypertension caused by lenvatinib using real‐world postmarketing surveillance data
por: Otani, Yuki, et al.
Publicado: (2021) -
Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan
por: NISHIKAWA, Ryo, et al.
Publicado: (2021) -
Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
por: Sakata, Yukinori, et al.
Publicado: (2019) -
Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data
por: Otani, Yuki, et al.
Publicado: (2021) -
Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study
por: Tsurutani, Junji, et al.
Publicado: (2018)